Skip to page content

CPC Scientific chooses Rocklin for biotech expansion


Biotech collaborations image
CPC Scientific's manufacturing operation in Rocklin will start with 50 jobs.
Getty Images; Kristina Walser / ACBJ

San Jose-based CPC Scientific Inc. will be opening a 41,000-square-foot manufacturing operation in Rocklin next year to produce synthetic peptides for the fast-growing therapeutics and diagnostics market.

The new location, in the Atherton Business Park, will start with 50 employees, the company said.

“The science may be complicated, but it’s easy to understand how this life-science leader can help build this industry cluster in the region and attract more companies and high paying jobs,” said Rocklin Mayor Bill Halldin, in a news release. “We have enjoyed getting to know the CPC Scientific leadership as they finalized their choice of Rocklin and look forward to their continued success in biotechnology and life-sciences.”

In an interview with the Business Journal, Halldin said Rocklin has been working with the company since February to ensure the new location can get permits as quickly as possible.

"The region has talked for years about attracting more companies in the life-sciences industry," Halldin said. He anticipates synergies with other local university and medical companies in the region.

Peptide-based therapeutics have been the fastest-growing sector among all the chemical-synthesized new chemical entities for new drug development in recent years, CPC said.

The Rocklin location will help the company diversify its supply chain. The company has an existing manufacturing plant in Hangzhou, China, which is just outside Shanghai.

The business park is near Sunset Boulevard and Highway 65 at the north end of Rocklin. CPC will take space in an existing building at 3880 Atherton Road.

Peptide therapeutics have been developed over a century to treat diseases including diabetes, cancer, osteoporosis, multiple sclerosis, HIV infection and others.

“CPC has helped many of our clients to bring an innovative drug into the market from a concept,” said CPC CEO Shawn Lee, in a news release. "With the new Rocklin site, we believe we will be able to contribute more, especially to the Northern American market, using our decades of peptide synthesis expertise to help our clients save lives and improve human health worldwide."

CPC was founded in 2001. On its website, the company says it can provide products from the milligram to multi-kilogram for research-grade peptides with purity up to 99%.


Keep Digging



SpotlightMore

Image via Getty
See More
SPOTLIGHT Awards
See More
Image via Getty Images
See More
SPOTLIGHT Tech News from the Local Business Journal
See More

Upcoming Events More

Want to stay ahead of who & what is next? The national Inno newsletter is your definitive first-look at the people, companies & ideas shaping and driving the U.S. innovation economy.

Sign Up
)
Presented By